Rigel Pharmaceuticals (RIGL) Gross Profit (QoQ) (2018 - 2026)
Rigel Pharmaceuticals (RIGL) Gross Profit (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | Rigel Pharmaceuticals | 704.07 Mn | 557.39 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.09% |
| Dec 31, 2025 | -1.33% |
| Sep 30, 2025 | -33.41% |
| Jun 30, 2025 | 98.64% |
| Mar 31, 2025 | -5.56% |
| Dec 31, 2024 | 9.57% |
| Sep 30, 2024 | 38.92% |
| Jun 30, 2024 | 23.72% |
| Mar 31, 2024 | -14.04% |
| Dec 31, 2023 | 19.12% |
| Sep 30, 2023 | 4.09% |
| Jun 30, 2023 | 2.86% |
| Mar 31, 2023 | -50.74% |
| Dec 31, 2022 | 129.86% |
| Sep 30, 2022 | -23.01% |
| Jun 30, 2022 | 73.25% |
| Mar 31, 2022 | -16.60% |
| Dec 31, 2021 | -6.87% |
| Sep 30, 2021 | -18.15% |
| Jun 30, 2021 | -67.61% |